John E Davies BDS, PhD, DSc. FBSE. Founding President & CEO
TRT’s original technology was developed by Davies through his academic research at the University of Toronto. He is internationally recognized as a leader in both biomaterials and mesenchymal stromal cell research.
Armand Keating MD, FRCSC, FRCPC. Founding Director & CMO
Keating is Professor of Medicine and Biomedical Engineering at the University of Toronto; and Senior Clinician Scientist at Princess Margaret Cancer Centre, Toronto.
Morris M Hosseini PhD. Founder
Hosseini is a Senior Partner at Roland Berger in the Pharma & Healthcare Competence Center in Berlin, Germany. Prior to joining Roland Berger, Hosseini worked as a researcher in regenerative medicine; his PhD is in Biomedical Engineering from the University of Toronto in Canada.